JVM Co

JVM Co Interest Expense

The Interest Expense of JVM Co (054950.KQ) as of Nov 3, 2026 is 3.55 B KRW. In the previous year, Interest Expense was 2.20 B KRW — a change of 60.95% (higher).

Interest Expense

3.55 BKRW

YoY

60.95%

Last updated:

Interest Expense of JVM Co is 2024 3.55 B KRW. Interest Expense of JVM Co was 2023 2.20 B KRW. It decreases by 60.95% higher compared to the previous year.

The JVM Co Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2017
-416.00 M KRW
Jan 1, 2018
938.00 M KRW
Jan 1, 2019
603.00 M KRW
Jan 1, 2020
-1.56 B KRW
Jan 1, 2021
130.52 M KRW
Jan 1, 2022
-3.98 M KRW
Jan 1, 2023
2.20 B KRW
Jan 1, 2024
3.55 B KRW
The JVM Co Interest Expense history
YEARInterest ExpenseYoY
3.55 BKRW+60.95%
2.20 BKRW-55,534.59%
-3.98 MKRW-103.05%
130.52 MKRW-108.37%
-1.56 BKRW-358.54%
603.00 MKRW-35.71%
938.00 MKRW-325.48%
-416.00 MKRW-149.46%
841.00 MKRW-33.73%
1.27 BKRW-7.03%
1.37 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Interest Expense of JVM Co is 3.55 B KRW in 2024.

Interest Expense of JVM Co changed from 2.20 B KRW to 3.55 B KRW, representing a 60.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense JVM Co since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's JVM Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — JVM Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — JVM Co